| Expression pattern: |
UN |
| Associated gene: |
IGF2BP3 |
| Associated microRNA: |
- |
| Biological function: |
hsa_circRNA_103820 suppresses lung cancer cell viability, migration and invasion, promotes apoptosis, and encodes a 188-aa peptide that inhibits malignant progression. |
| Molecular mechanism: |
IGF2BP3 interacts with hsa_circRNA_103820 in an m6A-dependent manner and negatively regulates its expression; hsa_circRNA_103820 encodes a 188-aa peptide that inhibits the AKT pathway. |
| Biological pathway or process: |
proliferation (inhibits); apoptosis (promotes); migration (inhibits); invasion (inhibits); PI3K/AKT/mTOR (inhibits); m6A modification (other); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; RIP (RNA Immunoprecipitation); MeRIP / MeRIP-seq; Transfection; CCK8; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
This study identifies hsa_circRNA_103820 as a suppressive circRNA in lung cancer cell progression. IGF2BP3 binds hsa_circRNA_103820 in an m6A-dependent manner and negatively regulates its expression, while hsa_circRNA_103820 encodes a functional 188-aa peptide that inhibits LC cell viability, migration and invasion and promotes apoptosis through inhibition of the AKT/PI3K/mTOR pathway. |
| Confidence score: |
0.6945 |